Meet PrecisionLife During Jefferies London Healthcare Conference and London Life Sciences Week
16–21 November
Victoria House, Bloomsbury Square London
PrecisionLife is redefining precision medicine for complex chronic diseases that affect more than 5 billion people and account for over 80% of global healthcare spending.
We will be in London for meetings during Jefferies Healthcare Conference and London Life Sciences Week, 16–21 November, and are welcoming discussions with prospective investors and partners.
Why PrecisionLife?
World-leading platform
Our proprietary AI-driven combinatorial analytics platform finds 10x more disease biology insight from just 10% of the data required by leading genomic analysis approaches or alternative AI models. These insights enable us to determine the mechanistic drivers of disease, identify risk factors, and predict treatment response in individuals, delivering clinical actionability at unprecedented resolution and scale.
Clear path to revenue across high-need disease areas
Our solutions are being deployed with leading US healthcare systems to improve patient flow and outcomes, reduce clinical waste, and shorten time to effective treatment across chronic diseases, including autoimmune, metabolic, and women’s health conditions. In doing so, we are also generating new and repeatable revenue opportunities for healthcare providers.
Strategic validation and momentum
We have secured new partnership agreements with major US academic medical centers and health system innovators, alongside additional participation in our Series A from strategic healthcare investors.
Route to regulatory approval
Our Mechanostic® products operate within established CLIA/CAP genotyping workflows. They benefit from a straightforward path to clinical accreditation and enable stratified clinical trial design and innovation in care pathway design across indications and care settings.
Experienced leadership team
Our leadership team includes senior executives with deep experience in life sciences, healthcare data, diagnostics, and large-scale commercial execution. See Leadership Team
Recent Progress
-
Secured additional strategic investment in our Series A from a major US healthcare provider
-
Signed an agreement to develop drug response biomarkers to inform GLP-1 reimbursement policy
-
Formed a collaboration with a leading Longevity & Healthspan innovation group
- Started patient recruitment with a leading US Academic Medical Center for a rheumatology triage program to reduce time to effective treatment
-
Returned groundbreaking results in a 400-patient clinical research study funded by the Complex Disorders Alliance (founded by Fidji Simo, CEO of OpenAI’s Applications business)
-
Forged new collaborations with US and EU centers of clinical excellence in endometriosis and pelvic pain leveraging a €2.5M Innovation Award to accelerate development of tests and treatments for up to 300 million women
Schedule a Meeting in London
We are hosting in-person investor and partner meetings at our Bloomsbury offices during Jefferies London Healthcare Conference and London Life Sciences Week.
Location
PrecisionLife, Victoria House, Bloomsbury Square
London WC1B 4DA
Request a meeting
Please complete the short form below to arrange a session with members of our executive team.
